MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0068886
Enaltec Pharma Research Private Limited - pharma in Ambernath, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.67 Cr
▼ 8% YoY
Net loss · FY 2025
₹3.48 Cr
Net margin -61.4%
EBITDA · FY 2025
₹57.1 Lakh
EBITDA margin 10.1%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹14.02 Lakh
Issued & subscribed
Open charges
₹14.68 Cr
Satisfied ₹48.85 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
40
Provident fund records
About Enaltec Pharma Research Private Limited
Data last updated:
Enaltec Pharma Research Private Limited is a private limited company based in Ambernath, Maharashtra, India, a subsidiary of Enaltec Labs Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 18 May 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC153404. Its GSTIN is 27AACCG3697A1ZP (Maharashtra).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹14.02 Lakh. It was formerly known as Getz Pharma Research Private Limited and Getz Pharma Private Limited. It is led by directors including Anand Prafulchandra Shah (Managing Director) and Samir Kumar.
Its last annual general meeting (AGM) was held on 11 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No Pl – 11 MIDC Addl Ambernath, Maharashtra, India – 421506.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.67 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹3.48 Cr (net margin -61.4%) and EBITDA of ₹57.1 Lakh (EBITDA margin 10.1%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 7% over five years.
The company has about 40 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Enaltec Labs. As per MCA filings, the company has open charges of ₹14.68 Cr and satisfied charges of ₹48.85 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Enaltec Pharma Research Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0068886). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website enaltec.com.
Company details
CIN U24230MH2005PTC153404
Registration Number 153404
Incorporation Date 18 May 2005
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 11 August 2025
Date of Balance Sheet 31 March 2025
Parent Company Enaltec Labs Private Limited
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0068886
Name history
Enaltec Pharma Research has undergone 3 name changes throughout its history. The company was previously known as Getz Pharma Research Private Limited, Getz Pharma Private Limited, and Enaltec Pharma Research Private Limited. The current legal name is Enaltec Pharma Research Private Limited.
| Company Name | Status |
|---|---|
| Enaltec Pharma Research Private Limited | Current |
| Getz Pharma Research Private Limited | Previous |
| Getz Pharma Private Limited | Previous |
Key People
Anand Prafulchandra Shah Managing Director Samir Kumar Nominee Director Vivek Gupta Nominee Director Recognitions & Rankings of Enaltec Pharma Research
Contact details
Enaltec Pharma Research Private Limited's registered office is in Ambernath, Maharashtra. Its website is enaltec.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No Pl – 11 MIDC Addl Ambernath, Maharashtra, India – 421506
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Enaltec Pharma Research Private Limited, buy the company report.
Comprehensive company report
Enaltec Pharma Research Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Enaltec Pharma Research operates one associated brand: Enaltec Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Non-oncology APIs are developed and manufactured by Enaltec Labs. | enaltec.com |
Business activity
The main business activity of Enaltec Pharma Research is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Enaltec Pharma Research Private Limited, buy the company report.
Financials of Enaltec Pharma Research Private Limited
FY 2025 filings availableEnaltec Pharma Research Private Limited reported revenue of ₹5.67 Cr (down 8% YoY) for FY 2025.
Revenue · FY 2025
₹5.67 Cr ▼ 8%
Net loss · FY 2025
₹3.48 Cr margin -61.4%
EBITDA · FY 2025
₹57.1 Lakh margin 10.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 17%
5 years · compounded
▼ 7%
EBITDA CAGR growth
1 year
▲ 145%
3 years · compounded
▲ 35%
5 years · compounded
▲ 16%
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 8% fall in the latest year. EBITDA rose 145% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹57.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.48 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | ||||
| Net Profit Margin | -61.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Enaltec Pharma Research Private Limited, buy the company report.
Board of directors of Enaltec Pharma Research Private Limited
Enaltec Pharma Research has 3 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samir Kumar Also directs: La Renon Healthcare Private Limited | Nominee Director | 14 Feb 2022 | 4 Years 8 Months | Current |
| Anand Prafulchandra Shah | Managing Director | 12 Sep 2009 | 17 Years 1 Months | Current |
| Vivek Gupta Also directs: La Renon Healthcare Private Limited | Nominee Director | 14 Feb 2022 | 4 Years 8 Months | Current |
Auditor
Enaltec Pharma Research Private Limited is audited by Parikh & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Parikh & Associates | FY 2023 | 146545W |
Shareholding
The shareholding of Enaltec Pharma Research Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Enaltec Pharma Research Private Limited, buy the company report.
Charges & borrowings
Open charges
₹14.68 Cr
Satisfied charges
₹48.85 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Oct 2020 | 100386842 | Hdfc Bank Limited | ₹1.18 Cr | Satisfied | |
| 16 Mar 2018 | 100176358 | Hdfc Bank Limited | ₹10 Cr | Satisfied | |
| 16 Mar 2018 | 100176362 | Hdfc Bank Limited | ₹3.5 Cr | Satisfied | |
| 13 Sep 2013 | 10458615 | Bmw India Financial Services Private Limited | ₹32 Lakh | Satisfied | |
| 06 Mar 2013 | 10413901 | Icici Bank Limited | ₹3.75 Cr | Satisfied |
To see the full charge records of Enaltec Pharma Research Private Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Enaltec Pharma Research Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Mumbai | Company petition | Filed against the company by Axar Pharmaceuticals Inc | Disposed |
To see the full case history of Enaltec Pharma Research Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Enaltec Pharma Research Private Limited has 9 MSME Form 1 returns on record between 2019 and 2024, listing 131 overdue payments to 24 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 24)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Aavanira Biotech Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Indtech Instruments Private Limited | |||
| Electrolab (India) Private Limited |
To see the full MSME payment records of Enaltec Pharma Research Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Enaltec Pharma Research Private Limited has a workforce of 40 employees on its EPFO records as of Sep 17, 2024, across 1 active EPFO establishment.
Employee count
40
Active EPFO establishments
1
Employee growth
-35.48%
GST
Enaltec Pharma Research has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCG3697A1ZP | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Enaltec Pharma Research Private Limited, buy the company report.
Recent activity
Enaltec Pharma Research Private Limited has 29 board changes on record since 2005: 16 appointments and 13 cessations. The latest: Neeraj Singh ceased to be Nominee Director on 23 Jun 2025.
AGM
Enaltec Pharma Research Private Limited last Annual general meeting of members was held on 11 Aug 2025 as per latest MCA records.
Ceased
Neeraj Singh ceased to be Nominee Director.
Ceased
Amit Bansilal Jain ceased to be Nominee Director.
Filing
Enaltec Pharma Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge registered on 20 Oct 2020 via Charge ID 100386842 with Hdfc Bank Limited was fully satisfied on 31 Jan 2025.
Charges
A charge registered on 16 Mar 2018 via Charge ID 100176358 with Hdfc Bank Limited was fully satisfied on 31 Jan 2025.
Charges
A charge registered on 16 Mar 2018 via Charge ID 100176362 with Hdfc Bank Limited was fully satisfied on 31 Jan 2025.
Ceased
Sumit Gupta ceased to be Nominee Director.
Ceased
Abhijit Basu ceased to be Director.
Appointed
Neeraj Singh was appointed as Nominee Director.
Ceased
Susheel Koul ceased to be Director.
Appointed
Abhijit Basu was appointed as Director.
43 earlier events are in the company report.
Frequently asked questions
Enaltec Pharma Research is an active private limited company based in Ambernath, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 18 May 2005 (21+ years old) and is registered under CIN U24230MH2005PTC153404.
Enaltec Pharma Research has 3 current directors:
- Anand Prafulchandra Shah - Managing Director
- Samir Kumar - Nominee Director
- Vivek Gupta - Nominee Director
The latest financial statements of Enaltec Pharma Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 11 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Enaltec Pharma Research is 27AACCG3697A1ZP, registered in Maharashtra.
The CIN (Corporate Identification Number) of Enaltec Pharma Research is U24230MH2005PTC153404. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Enaltec Pharma Research has 1 court case on record: 1 filed against it.
Enaltec Pharma Research was incorporated on 18 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Neeraj Singh ceased to be Nominee Director on 23 Jun 2025. Amit Bansilal Jain ceased to be Nominee Director on 03 Jun 2025. Sumit Gupta ceased to be Nominee Director on 26 Oct 2024. Enaltec Pharma Research has 29 board changes on record in total.
Yes, Enaltec Pharma Research is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0068886).
Enaltec Pharma Research has 9 MSME Form 1 returns on record between 2019 and 2024, listing 131 overdue payments to 24 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Enaltec Pharma Research can be reached through the website enaltec.com. Its registered office is in Ambernath, Maharashtra, India.